Sort by
INIS
doses
97%
drugs
73%
brain
59%
administration
50%
comparative evaluations
39%
humans
34%
levels
32%
concentration
30%
assessments
29%
populations
29%
dissolution
29%
symptoms
27%
reduction
25%
psychological behavior
25%
safety
24%
pain
23%
lysergic acid
22%
surveys
21%
patients
21%
reviews
21%
control
20%
data
19%
dynamics
19%
analgesics
19%
performance
18%
receptors
16%
legal aspects
15%
peaks
15%
interactions
14%
tolerance
13%
Keyphrases
Psychedelics
100%
Ayahuasca
52%
Cannabis
52%
Psilocybin
50%
Healthy Volunteers
31%
Lysergic Acid Diethylamide
20%
Subjective Experience
19%
Altered States of Consciousness
19%
Cannabis Users
19%
Placebo-controlled
19%
Well-being
18%
4-fluoroamphetamine
18%
5-methoxy-N,N-dimethyltryptamine
18%
Microdosing
18%
Ego Dissolution
17%
Ceremony
17%
Placebo
15%
Neuroadaptation
15%
Placebo-controlled Study
15%
Synthetic Cannabinoids
15%
Cannabis Use
14%
Neurocognition
14%
JWH-018
13%
Empathy
13%
Life Satisfaction
13%
Creative Thinking
12%
Δ9-tetrahydrocannabinol (Δ9-THC)
12%
Glutamate
12%
Acute Effects
12%
Mental Health
11%